Interrogating the role of mutant KRAS allelic imbalance and co-mutated genes in targeted therapy response of NSCLC Grant uri icon

Overview

date/time interval

  • August 9, 2021 - August 8, 2025

sponsor award ID

  • 1 F31 CA261061-01A1

Affiliation